Database for Clinical and Anamnestic Data in Pulmonary Hypertension

Recruiting Observational Study
Pulmonary Hypertension
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
900 (estimated)
Sponsor
Medical University of Graz · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg measured in the right heart catheterization. There are different forms of PH defined in the classification of Dana Point 2008. PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like the echocardiography, stress echocardiography a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients with pulmonary hypertension * patients at risk for getting pulmonary hypertension * patients who have symptoms which my be due to pulmonary hypertension when we have their written informed consent. Exclusion Criteria: * patients without written informed consent
Contacts

Horst Olschewski, MD

+43-316-385-12183

horst.olschewski@medunigraz.at

CONTACT

Maria Tscherner, MD

+43-316-385-12183

m.tscherner@medunigraz.at

CONTACT